Fennec Pharmaceuticals is trading 5.1% up now at $12.37, with no clearly attributable company-specific announcement identified.

  • No company-specific announcement dated August 28, 2026, was identified.
  • The latest company release located was the August 11 second-quarter report; the investor calendar showed no current events.
  • Biotech is broadly weaker, with XBI down 2.31%, so the gain appears unexplained by available sector or macro evidence.